| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10969400 | Vaccine | 2012 | 8 Pages |
Abstract
⺠Chikungunya virus vaccines: recombinant E2 protein and inactivated virus based. ⺠High level of ELISA/neutralizing antibody (nAb) titres elicited in vaccinated mice. ⺠nAbs were cross reactive with heterologous genotype of virus. ⺠Long lasting complete protection by all candidate vaccines. ⺠Alum being the most effective adjuvant.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Manish Kumar, A.B. Sudeep, Vidya A. Arankalle,